Evolving paradigm for imaging, diagnosis, and management of DCIS

Journal of the American College of Radiology

Volumn 10, Issue 12, 2013, Pages 918-923

  Wells, Colin J ^a   O'Donoghue, Cristina ^b   Ojeda Fournier, Haydee ^c   Retallack, Hanna E G ^d   Esserman, Laura J ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

breast cancer; Ductal carcinoma in situ; overtreatment; risk assessment; screening

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER SCREENING; COMMUNICATION DISORDER; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; ECONOMICS; FALSE POSITIVE RESULT; HUMAN; INFORMATION PROCESSING; INTRADUCTAL CARCINOMA; MALPRACTICE; MAMMOGRAPHY; RISK ASSESSMENT; TUMOR BIOPSY; TUMOR INVASION;

BREAST CANCER; DUCTAL CARCINOMA IN SITU; OVERTREATMENT; RISK ASSESSMENT; SCREENING;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; RADIOGRAPHIC IMAGE ENHANCEMENT; RISK ASSESSMENT;

EID: 84889246204     PISSN: 15461440     EISSN: 1558349X     Source Type: Journal    
DOI: 10.1016/j.jacr.2013.09.011     Document Type: Article

References (55)

1. Esserman LJ, Thompson IM, Reid B. Addressing the emergence of over-diagnosis and overtreatment in cancer: an opportunity for improvement and change. JAMA. In press.
2. L. Esserman, I. Thompson, and B.J. Reid Over-diagnosis and overtreatment in cancer: an opportunity for improvement JAMA 310 2013 797 798
3. C. Sotiriou, and L. Pusztai Gene-expression signatures in breast cancer N Engl J Med 360 2009 790 800
4. K.D. Voduc, M.C.U. Cheany, S. Tyldesley, K. Gelmon, T.O. Nielsen, and H. Kennecke Breast cancer subtypes and the risk of local and regional relapse J Clin Oncol 28 2010 1684 1691
5. S. Paik, S. Shak, and G. Tang A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2004 2817 2826
6. M. Buyse, S. Loi, and L. van't Veer Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer J Natl Cancer Inst 98 2006 1183 1192
7. R.W. Blamey, T. Bates, and U. Chetty Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial Eur J Cancer 49 2013 2294 2302
8. L.J. Solin, R. Gray, and F.L. Baehner A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast J Natl Cancer Inst 105 2013 701 710
9. L. Esserman, Y. Shieh, and I. Thompson Rethinking screening for breast cancer and prostate cancer JAMA 302 2009 1685 1692
10. J.J. Farrell, and C. Fernandez-Del Castillo Pancreatic cystic neoplasms: management and unanswered questions Gastroenterology 144 2013 1303 1315
11. B.J. Reid, X. Li, P.C. Galipeau, and T.L. Vaughan Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis Nat Rev Cancer 10 2010 87 101
12. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics 2012 CA Cancer J Clin 62 2012 10 29
13. B. Erbas, E. Provenzano, J. Armes, and D. Gertig The natural history of ductal carcinoma in situ of the breast: a review Breast Cancer Res Treat 97 2006 135 144
14. E.M. Ozanne, Y. Shieh, J. Barnes, C. Bouzan, E.S. Hwang, and L.J. Esserman Characterizing the impact of 25 years of DCIS treatment Breast Cancer Res Treat 129 2011 165 173
15. Solin LJ, et al. An international collaborative study: a 15-year experience. In: Ductal carcinoma of the breast. 2nd ed. Silverstein MJ, editor. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 359-366.
16. L.J. Solin, A. Fourquet, and F.A. Vicini Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast Cancer 103 2005 1137 1146
17. K. Kerlikowske, A.M. Molinaro, and M.L. Gauthier Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis J Natl Cancer Inst 102 2010 627 637
18. A.N. Freedman, B.I. Graubard, S.R. Rao, W. McCaskill-Stevens, R. Ballard-Barbash, and M.H. Gail Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention J Natl Cancer Inst 95 2003 526 532
19. B. Fisher, J.P. Costantino, and D.L. Wickerham Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study J Natl Cancer Inst 97 2005 1652 1662
20. V.L. Tsikitis, and M.A. Chung Biology of ductal carcinoma in situ classification based on biologic potential Am J Clin Oncol 29 2006 305 310
21. T.M. Tuttle, S. Jarosek, and E.B. Habermann Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ J Clin Oncol 27 2009 1362 1367
22. S.L. Gomez, D. Lichtensztajn, and A.W. Kurian Increasing mastectomy rates for early-stage breast cancer? Population-based trends from California J Clin Oncol 28 2010 e155 e157
23. P.A. Carney, E.A. Sickles, and B.S. Monsees Identifying minimally acceptable interpretive performance criteria for screening mammography Radiology 255 2010 354 361
24. P.A. Carney, J. Parikh, and E.A. Sickles Diagnostic mammography: identifying minimally acceptable interpretive performance criteria Radiology 267 2013 359 367
25. E.A. Sickles Successful methods to reduce false-positive mammography interpretations Radiol Clin North Am 38 2000 693 700
26. L.W. Bassett, R.E. Hendrick, and T. Bassford Quality determinants of mammography: clinical practice guidelines, No. 13 1994 US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research Rockville, Maryland
27. L.J. Esserman, Y. Shieh, and E.J. Rutgers Impact of mammographic screening on the detection of good and poor prognosis breast cancers Breast Cancer Res Treat 130 2011 725 734
28. H. Rahbar, S.C. Partridge, and W.B. Demartini In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters Radiology 263 2012 374 382
29. K. Michailidou, P. Hall, and A. Gonzalez-Neira Large-scale genotyping identifies 41 new loci associated with breast cancer risk Nat Genet 45 2013 353 362
30. E.S. Burnside, J. Davis, and J. Chhatwal Probabilistic computer model developed from clinical data in national mammography database format to classify mammographic findings Radiology 251 2009 663 672
31. R.L. Birdwell, C.E. Mountford, and J.D. Iglehart Molecular imaging of the breast AJR Am J Roentgenol 193 2009 367 376
32. T.H. Oude Munnink, W.B. Nagengast, and A.H. Brouwers Molecular imaging of breast cancer Breast 18 suppl 2009 S66 S73
33. H. Kaur, S. Mao, and S. Shah Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ Expert Rev Molec Diagn 13 2013 151 165
34. J.G. Elmore, C.Y. Nakano, T.D. Koepsell, L.M. Desnick, C.J. D'Orsi, and D.F. Ransohoff International variation in screening mammography interpretations in community-based programs J Natl Cancer Inst 95 2003 1384 1393
35. R. Smith-Bindman, P.W. Chu, and D.L. Miglioretti Comparison of screening mammography in the United States and the United kingdom JAMA 290 2003 2129 2137
36. B.M. Geller, L.E. Ichikawa, and D.S. Buist Improving the concordance of mammography assessment and management recommendations Radiology 241 2006 67 75
37. S.P. Poplack, A.N. Tosteson, M.R. Grove, W.A. Wells, and P.A. Carney Mammography in 53,803 women from the New Hampshire mammography network Radiology 217 2000 832 840
38. R.A. Hubbard, K. Kerlikowske, C.I. Flowers, B.C. Yankaskas, W. Zhu, and D.L. Miglioretti Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study Ann Intern Med 155 2011 481 492
39. K. Blanchard, J.A. Colbert, and D.B. Kopans Long-term risk of false-positive screening results and subsequent biopsy as a function of mammography use Radiology 240 2006 335 342
40. S.G. Baker, and B.S. Kramer Estimating the cumulative risk of a false-positive under a regimen involving various types of cancer screening tests J Med Screen 15 2008 18 22
41. L. Esserman, H. Cowley, and C. Eberle Improving the accuracy of mammography: volume and outcome relationships J Natl Cancer Inst 94 2002 369 375
42. K. Kerlikowske, R.A. Hubbard, and D.L. Miglioretti Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study Ann Intern Med 155 2011 493 502
43. C.K. Bent, L.W. Bassett, C.J. D'Orsi, and J.W. Sayre The positive predictive value of BI-RADS microcalcification descriptors and final assessment categories AJR Am J Roentgenol 194 2010 1378 1383
44. D.L. Weaver, R.D. Rosenberg, and W.E. Barlow Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography Cancer 106 2006 732 742
45. I. Andersson, L. Janzon, and B.F. Sigfusson Mammographic breast cancer screening - a randomized trial in Malmo, Sweden Maturitas 7 1985 21 29
46. National Health Service Consolidated guidance on standards for the NHS Breast Screening Programme 2005 NHS Cancer Screening Programmes Sheffield, United Kingdom
47. C.I. Flowers, C. O'Donoghue, and D. Moore Reducing false-positive biopsies: a pilot study to reduce benign biopsy rates for BI-RADS 4A/B assessments through testing risk stratification and new thresholds for intervention Breast Cancer Res Treat 139 2013 769 777
48. A.S. Saber Tehrani, H. Lee, and S.C. Mathews 25-Year summary of US malpractice claims for diagnostic errors 1986-2010: an analysis from the National Practitioner Data Bank BMJ Qual Safety 22 2013 672 680
49. J.G. Elmore, S.H. Taplin, and W.E. Barlow Does litigation influence medical practice? The influence of community radiologists' medical malpractice perceptions and experience on screening mammography Radiology 236 2005 37 46
50. J.S. Whang, S.R. Baker, R. Patel, L. Luk, and A. Castro III The causes of medical malpractice suits against radiologists in the United States Radiology 266 2013 548 554
51. L.J. van't Veer, and R. Bernards Enabling personalized cancer medicine through analysis of gene-expression patterns Nature 452 2008 564 570
52. A. Bleyer, and G. Welch Effect of three decades of screening mammography on breast-cancer incidence N Engl J Med 367 2012 1998 2005
53. C. O'Donoghue, and L. Esserman Recognising the benefits and harms of breast cancer screening: an opportunity to target improvement Br J Cancer 108 2013 2200 2201
54. T.M. Tuttle, S. Jarosek, and E.B. Habermann Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ J Clin Oncol 27 2009 1362 1367
55. E.S. Hwang The impact of surgery on ductal carcinoma in situ outcomes: the use of mastectomy Jf Natl Cancer Inst Monogr 41 2010 197 199